BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21741199)

  • 21. Significance analysis of histologic type and perineural invasion as prognostic factors after curative resection of ampulla of Vater carcinoma.
    Lee JH; Lee KG; Ryou H; Jun YJ; Paik SS; Park HK; Lee KS
    Hepatogastroenterology; 2010; 57(99-100):646-52. PubMed ID: 20698243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Important prognostic factors in adenocarcinoma of the ampulla of Vater.
    Lowe MC; Coban I; Adsay NV; Sarmiento JM; Chu CK; Staley CA; Galloway JR; Kooby DA
    Am Surg; 2009 Sep; 75(9):754-60; discussion 761. PubMed ID: 19774945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma.
    Schwarz RE; Keny H
    Hepatogastroenterology; 2001; 48(41):1493-8. PubMed ID: 11677994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
    Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
    J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinoma of the ampulla of Vater: results of surgical treatment of a single center.
    Memon MA; Shiwani MH; Anwer S
    Hepatogastroenterology; 2004; 51(59):1275-7. PubMed ID: 15362731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinico-morphological factors of prognosis in cancer of the major duodenum papilla].
    Alibegov RA; Prokhorenko TI; Sergeev OA; Khlusov AN
    Vestn Khir Im I I Grek; 2008; 167(2):26-8. PubMed ID: 18522181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic implication of common bile duct infiltration in adenocarcinoma of the ampulla of Vater after pancreaticoduodenectomy].
    Wu TC; Shao YF; Shan Y; Wu JX; Zhao DB; Xu LB; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):775-8. PubMed ID: 19173811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of surgical treatment for ampullary carcinoma.
    Shinkawa H; Takemura S; Kiyota S; Uenishi T; Kaneda K; Sakae M; Urata Y; Ohata K; Nozawa A; Kubo S
    Hepatogastroenterology; 2012 Jun; 59(116):1010-2. PubMed ID: 22580650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant therapy for ampullary carcinomas: the Mayo Clinic experience.
    Bhatia S; Miller RC; Haddock MG; Donohue JH; Krishnan S
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):514-9. PubMed ID: 16863684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
    O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nodal involvement as an indicator of postoperative liver metastasis in carcinoma of the papilla of Vater.
    Moriya T; Kimura W; Hirai I; Mizutani M; Ma J; Kamiga M; Fuse A
    J Hepatobiliary Pancreat Surg; 2006; 13(6):549-55. PubMed ID: 17139430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct.
    Hughes MA; Frassica DA; Yeo CJ; Riall TS; Lillemoe KD; Cameron JL; Donehower RC; Laheru DA; Hruban RH; Abrams RA
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):178-82. PubMed ID: 17276614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing lymph node metastasis in patients with ampullary adenocarcinoma.
    Okano K; Asano E; Kushida Y; Kamada H; Mori H; Suzuki Y
    Dig Surg; 2014; 31(6):459-67. PubMed ID: 25613423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of failure after pancreaticoduodenectomy for ampullary carcinoma.
    Willett CG; Warshaw AL; Convery K; Compton CC
    Surg Gynecol Obstet; 1993 Jan; 176(1):33-8. PubMed ID: 8093983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of adjuvant chemoradiotherapy for ampulla of Vater cancer.
    Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):436-41. PubMed ID: 19394162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinoma of the ampulla of Vater: a community hospital experience.
    Sticca RP; Weatherford DA; McAlhany JC
    Am Surg; 1996 Mar; 62(3):197-202. PubMed ID: 8607578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical significance of solitary lymph node metastasis in carcinoma of the ampulla of Vater].
    Shan Y; Zhao DB; Che X; Wang JX; Shao YF; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):694-6. PubMed ID: 17274378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does lymph node ratio impact survival in resected periampullary malignancies?
    Hurtuk MG; Hughes C; Shoup M; Aranha GV
    Am J Surg; 2009 Mar; 197(3):348-52. PubMed ID: 19245913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological characteristics and surgical procedures for carcinoma of the papilla of Vater.
    Futakawa N; Kimura W; Wada Y; Muto T
    Hepatogastroenterology; 1996; 43(7):260-7. PubMed ID: 8682475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.